BRCA1 and neoplasm: We aimed to identify whether PFS or OS may be associated with factors such as age, sex, smoking status, histopathology, tumor stage, combined with anti-angiogenic therapy status, TKI-targeted therapy before chemotherapy status, HR gene mutation, BRCA1/2 mutation, and driver gene mutation status.